Reflux Meds and Fatty Liver?
from What's the Root Cause? by Dr Vikki Petersen Hosted by Root Cause Medical Clinic
Fatty liver prevalence is 40% and most people don’t know they have it. It's closely tied to diabetes, heart disease, and long-term liver damage. In this episode, Dr Vikki Petersen explains the association between PPI medication and fatty liver. Secret #1 Observational studies have found that people taking proton pump inhibitors have a higher prevalence of Fatty Liver Risk -dose and duration dependent (1–2 years) The mechanism: gut microbiome disruption PPIs reduce stomach acid → that changes what survives the upper GI tract. leads to: Increased bacterial overgrowth - SIBO link - PPIs are strongly linked with SIBO - creates gas, pressure and reflux. Toxin-producing bacteria - lead to liver fat accumulation PPI → SIBO → pressure + endotoxins → reflux + fatty liver PPIs change the gut in a way that makes the body send more fat to the liver. Secret #2: Your gut talks to your liver Almost everything absorbed from your intestines travels straight to the liver first. 1. The wrong bacteria start to grow when stomach acid is suppressed. You start getting more bacteria that create irritating byproducts. 2. Those bacteria produce toxins 3. The gut lining gets irritated and more permeable 4. Those toxins slip into the bloodstream 5. They go straight to the liver. Blood from the intestines goes directly to the liver through the portal vein. 6. The liver reacts like it’s under attack and activates an inflammatory response. 7. Changes how the liver handles fat- burning is less efficient and the fat export system gets impaired - the result is fat accumulating inside liver cells. 8. Fat plus inflammation is where the real problem starts That combination is what can drive progression from simple fatty liver toward a more damaged, inflamed liver. Secret #3 - fix the gut signal coming into your liver - the focus isn’t on the liver but what’s being sent to it. Restore stomach acid or stop suppressing it. It’s how you prevent bacterial overgrowth. Reduce overgrowth and fermentation TIPS: Stop snacking Space meals 4 hours apart - MMC cleans house Chew thoroughly Walk after meals Strengthen gut barrier Eat whole foods - add polyphenols (berries, broccoli, tea, cacao,nuts and seeds) Fiber Get adequate high quality protein Remove triggers - ultra-processed foods, alcohol, sugar Lower the fat coming into your liver Reduce insulin spikes w/ less frequent eating Reduce excess sugar/fructose intake Improve insulin sensitivity w/ movement after meals and exercise - aerobic and resistance training helps manage blood sugar levels for 24 to 72 hours. If you’ve tried the basics and aren’t improving, it usually means something deeper is driving it—and that’s where a more comprehensive evaluation makes the difference.That’s exactly what we focus on—identifying and addressing the root causes behind these patterns, not just managing the surface symptoms evaluation of: SIBO / dysbiosis Gut barrier function Inflammation markers Insulin resistance / metabolic markers Liver function beyond basic labs References: 1. Pyo JH et al. Proton pump inhibitors use and the risk of fatty liver disease 2021, Journal of Gastroenterology and Hepatology 2. Yu H et al. Proton pump inhibitor use is associated with increased hepatic steatosis in US adults 2024, Biomedical Reports 3. Huang H et al. Long-term use of proton pump inhibitors is associated with increased risk of nonalcoholic fatty liver disease 2024, Journal of Clinical Gastroenterology 4. Fossmark R et al. Changes in the gastrointestinal microbiota induced by proton pump inhibitors 2024, Microorganisms #guthealth #acidreflux #fattyliver Disclaimer: The information provided in this episode is intended for educational p
Embed this episode
What this episode covers
Fatty liver prevalence is 40% and most people don’t know they have it. It's closely tied to diabetes, heart disease, and long-term liver damage. In this episode, Dr Vikki Petersen explains the association between PPI medication and fatty liver. Secret #1 Observational studies have found that people taking proton pump inhibitors have a higher prevalence of Fatty Liver Risk -dose and duration dependent (1–2 years) The mechanism: gut microbiome disruption PPIs reduce stomach acid →...
No transcript yet.